Tratamiento de la anemia en pacientes en hemodiálisis crónica (HDC) con dosis bajas de eritropoyetina recombinante (r-HuEPO) asociada o no a andrógenos
P. RENDO , A. CUSUMANO , C. MACHERONI , J. C. SÁNCHEZ AVALOS
Leído
8345
Vecesse ha leído el artículo
2220
Total PDF
6125
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 48 | 13 | 61 |
| 2025 5 | 91 | 45 | 136 |
| 2025 4 | 71 | 27 | 98 |
| 2025 3 | 88 | 43 | 131 |
| 2025 2 | 62 | 29 | 91 |
| 2025 1 | 56 | 46 | 102 |
| 2024 12 | 54 | 19 | 73 |
| 2024 11 | 56 | 44 | 100 |
| 2024 10 | 50 | 39 | 89 |
| 2024 9 | 68 | 33 | 101 |
| 2024 8 | 85 | 87 | 172 |
| 2024 7 | 58 | 27 | 85 |
| 2024 6 | 69 | 30 | 99 |
| 2024 5 | 77 | 34 | 111 |
| 2024 4 | 67 | 25 | 92 |
| 2024 3 | 42 | 14 | 56 |
| 2024 2 | 32 | 33 | 65 |
| 2024 1 | 26 | 18 | 44 |
| 2023 12 | 24 | 25 | 49 |
| 2023 11 | 38 | 26 | 64 |
| 2023 10 | 46 | 29 | 75 |
| 2023 9 | 65 | 25 | 90 |
| 2023 8 | 48 | 21 | 69 |
| 2023 7 | 64 | 24 | 88 |
| 2023 6 | 44 | 19 | 63 |
| 2023 5 | 33 | 26 | 59 |
| 2023 4 | 33 | 20 | 53 |
| 2023 3 | 36 | 17 | 53 |
| 2023 2 | 21 | 13 | 34 |
| 2022 1 | 37 | 24 | 61 |
| 2022 12 | 40 | 25 | 65 |
| 2022 11 | 44 | 25 | 69 |
| 2022 10 | 47 | 46 | 93 |
| 2022 9 | 36 | 20 | 56 |
| 2022 8 | 51 | 42 | 93 |
| 2022 7 | 43 | 36 | 79 |
| 2022 6 | 30 | 32 | 62 |
| 2022 5 | 33 | 33 | 66 |
| 2022 4 | 59 | 39 | 98 |
| 2022 3 | 41 | 46 | 87 |
| 2022 2 | 36 | 35 | 71 |
| 2021 1 | 24 | 37 | 61 |
| 2021 12 | 31 | 36 | 67 |
| 2021 11 | 38 | 32 | 70 |
| 2021 10 | 24 | 34 | 58 |
| 2021 9 | 33 | 35 | 68 |
| 2021 8 | 30 | 44 | 74 |
| 2021 7 | 22 | 19 | 41 |
| 2021 6 | 27 | 19 | 46 |
| 2021 5 | 30 | 32 | 62 |
| 2021 4 | 127 | 50 | 177 |
| 2021 3 | 72 | 17 | 89 |
| 2021 2 | 69 | 14 | 83 |
| 2020 1 | 62 | 15 | 77 |
| 2020 12 | 73 | 10 | 83 |
| 2020 11 | 38 | 11 | 49 |
| 2020 10 | 49 | 12 | 61 |
| 2020 9 | 43 | 10 | 53 |
| 2020 8 | 48 | 4 | 52 |
| 2020 7 | 38 | 11 | 49 |
| 2020 6 | 70 | 7 | 77 |
| 2020 5 | 60 | 10 | 70 |
| 2020 4 | 56 | 17 | 73 |
| 2020 3 | 76 | 16 | 92 |
| 2020 2 | 66 | 21 | 87 |
| 2020 1 | 64 | 14 | 78 |
| 2019 12 | 43 | 17 | 60 |
| 2019 11 | 31 | 11 | 42 |
| 2019 10 | 48 | 15 | 63 |
| 2019 9 | 43 | 21 | 64 |
| 2019 8 | 40 | 17 | 57 |
| 2019 7 | 73 | 23 | 96 |
| 2019 6 | 83 | 7 | 90 |
| 2019 5 | 89 | 33 | 122 |
| 2019 4 | 119 | 14 | 133 |
| 2019 3 | 79 | 17 | 96 |
| 2019 2 | 43 | 12 | 55 |
| 2019 1 | 24 | 6 | 30 |
| 2018 12 | 53 | 19 | 72 |
| 2018 11 | 35 | 12 | 47 |
| 2018 10 | 33 | 7 | 40 |
| 2018 9 | 32 | 10 | 42 |
| 2018 8 | 37 | 10 | 47 |
| 2018 7 | 30 | 14 | 44 |
| 2018 6 | 33 | 11 | 44 |
| 2018 5 | 33 | 8 | 41 |
| 2018 4 | 40 | 7 | 47 |
| 2018 3 | 31 | 7 | 38 |
| 2018 2 | 11 | 2 | 13 |
| 2018 1 | 25 | 9 | 34 |
| 2017 12 | 29 | 6 | 35 |
| 2017 11 | 20 | 14 | 34 |
| 2017 10 | 22 | 4 | 26 |
| 2017 9 | 17 | 7 | 24 |
| 2017 8 | 21 | 5 | 26 |
| 2017 7 | 18 | 7 | 25 |
| 2017 6 | 21 | 4 | 25 |
| 2017 5 | 25 | 6 | 31 |
| 2017 4 | 16 | 14 | 30 |
| 2017 3 | 11 | 7 | 18 |
| 2017 2 | 15 | 6 | 21 |
| 2016 1 | 19 | 12 | 31 |
| 2016 12 | 31 | 8 | 39 |
| 2016 11 | 67 | 5 | 72 |
| 2016 10 | 69 | 9 | 78 |
| 2016 9 | 78 | 7 | 85 |
| 2016 8 | 111 | 2 | 113 |
| 2016 7 | 88 | 7 | 95 |
| 2016 6 | 110 | 0 | 110 |
| 2016 5 | 116 | 0 | 116 |
| 2016 4 | 64 | 0 | 64 |
| 2016 3 | 60 | 0 | 60 |
| 2016 2 | 70 | 0 | 70 |
| 2015 1 | 92 | 0 | 92 |
| 2015 12 | 81 | 0 | 81 |
| 2015 11 | 66 | 0 | 66 |
| 2015 10 | 81 | 0 | 81 |
| 2015 9 | 80 | 0 | 80 |
| 2015 8 | 70 | 0 | 70 |
| 2015 7 | 51 | 0 | 51 |
| 2015 6 | 33 | 0 | 33 |
| 2015 5 | 36 | 0 | 36 |
| 2015 4 | 8 | 0 | 8 |
| 2015 2 | 2 | 0 | 2 |
Mostrar todo
